ITMI922331A0 - Uso di paratormone suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto protermine ed in generale per il trattamento della gestazione - Google Patents

Uso di paratormone suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto protermine ed in generale per il trattamento della gestazione

Info

Publication number
ITMI922331A0
ITMI922331A0 IT92MI2331A ITMI922331A ITMI922331A0 IT MI922331 A0 ITMI922331 A0 IT MI922331A0 IT 92MI2331 A IT92MI2331 A IT 92MI2331A IT MI922331 A ITMI922331 A IT MI922331A IT MI922331 A0 ITMI922331 A0 IT MI922331A0
Authority
IT
Italy
Prior art keywords
paratormone
gestation
abortion
therapy
prevention
Prior art date
Application number
IT92MI2331A
Other languages
English (en)
Inventor
Franco Bagnoli
Original Assignee
Franco Bagnoli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Franco Bagnoli filed Critical Franco Bagnoli
Publication of ITMI922331A0 publication Critical patent/ITMI922331A0/it
Priority to ITMI922331A priority Critical patent/IT1255723B/it
Priority to US08/411,726 priority patent/US5880093A/en
Priority to AT93922531T priority patent/ATE152628T1/de
Priority to JP6509588A priority patent/JPH08502271A/ja
Priority to NZ256679A priority patent/NZ256679A/en
Priority to CA002146666A priority patent/CA2146666A1/en
Priority to EP93922531A priority patent/EP0663835B1/en
Priority to DK93922531.4T priority patent/DK0663835T3/da
Priority to KR1019950701350A priority patent/KR100293846B1/ko
Priority to AU51499/93A priority patent/AU680631B2/en
Priority to DE69310528T priority patent/DE69310528T2/de
Priority to ES93922531T priority patent/ES2103493T3/es
Priority to PCT/EP1993/002755 priority patent/WO1994008613A2/en
Publication of ITMI922331A1 publication Critical patent/ITMI922331A1/it
Priority to NO19951050A priority patent/NO317930B1/no
Application granted granted Critical
Publication of IT1255723B publication Critical patent/IT1255723B/it
Priority to GR970401802T priority patent/GR3024157T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
ITMI922331A 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione IT1255723B (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
KR1019950701350A KR100293846B1 (ko) 1992-10-09 1993-10-08 임신치료를위한파라소먼,그생물학적활성프래그먼트및관련펩티드의용도
DE69310528T DE69310528T2 (de) 1992-10-09 1993-10-08 Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
JP6509588A JPH08502271A (ja) 1992-10-09 1993-10-08 パラトルモン、その生物学的活性フラグメント及び関連ペプチドの妊娠時の治療への使用
NZ256679A NZ256679A (en) 1992-10-09 1993-10-08 Use of parathormone (parathyroid hormone) in prevention and therapy of abortion and of premature birth
CA002146666A CA2146666A1 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
EP93922531A EP0663835B1 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
DK93922531.4T DK0663835T3 (da) 1992-10-09 1993-10-08 Anvendelse af parathormon, dets biologisk aktive fragmenter og relaterede peptider til behandling af graviditet
US08/411,726 US5880093A (en) 1992-10-09 1993-10-08 Use of parathormone, its biologically active fragments and correlated peptides, for the preparation of pharmaceutical compositions useful for the treatment of pregnancy
AU51499/93A AU680631B2 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
AT93922531T ATE152628T1 (de) 1992-10-09 1993-10-08 Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
ES93922531T ES2103493T3 (es) 1992-10-09 1993-10-08 Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
PCT/EP1993/002755 WO1994008613A2 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
NO19951050A NO317930B1 (no) 1992-10-09 1995-03-20 Anvendelse av paratyroidhormon, dets biologisk aktive fragmenter og korrelerte peptider for fremstilling av farmasoytiske blandinger for behandling under svangerskap.
GR970401802T GR3024157T3 (en) 1992-10-09 1997-07-17 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione

Publications (3)

Publication Number Publication Date
ITMI922331A0 true ITMI922331A0 (it) 1992-10-09
ITMI922331A1 ITMI922331A1 (it) 1994-04-09
IT1255723B IT1255723B (it) 1995-11-13

Family

ID=11364090

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione

Country Status (14)

Country Link
US (1) US5880093A (it)
EP (1) EP0663835B1 (it)
JP (1) JPH08502271A (it)
KR (1) KR100293846B1 (it)
AT (1) ATE152628T1 (it)
AU (1) AU680631B2 (it)
CA (1) CA2146666A1 (it)
DE (1) DE69310528T2 (it)
DK (1) DK0663835T3 (it)
ES (1) ES2103493T3 (it)
GR (1) GR3024157T3 (it)
IT (1) IT1255723B (it)
NZ (1) NZ256679A (it)
WO (1) WO1994008613A2 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
ATE363289T1 (de) * 1995-02-20 2007-06-15 Yukio Kato Heilmittel für arthrosis deformans und entzündliche gelenkerkrankungen
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
US6043981A (en) * 1997-11-13 2000-03-28 Chrysler Corporation Heat sink assembly for electrical components
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
MY120063A (en) † 1997-12-09 2005-08-30 Lilly Co Eli Stabilized teriparatide solutions
EP1123401A1 (en) * 1998-10-22 2001-08-16 The General Hospital Corporation BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
AU2002339843B2 (en) * 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
JP4541899B2 (ja) * 2003-01-24 2010-09-08 ザ ジェネラル ホスピタル コーポレイション ラクタム架橋を有する、コンホメーションが制限された副甲状腺ホルモン（ｐｔｈ）アナログ
AU2003220380A1 (en) * 2003-03-19 2004-11-19 Bristol-Myers Squibb Company CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH Alpha-HELIX STABILIZERS
JP4871128B2 (ja) 2003-07-17 2012-02-08 ザ ジェネラル ホスピタル コーポレイション 高次構造的に制約された副甲状腺ホルモン（ｐｔｈ）アナログ
EP1744683B1 (en) 2004-05-13 2016-03-16 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US20080014186A1 (en) * 2004-05-26 2008-01-17 Green Peptide Co., Ltd. Hla-A24 or Hla-A2 Binding Peptides of Parathyroid Hormone-Related Protein
WO2008019062A2 (en) * 2006-08-04 2008-02-14 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
MX346714B (es) * 2007-08-01 2017-03-24 The General Hospital Corp * Metodos de analisis y seleccion usando receptores acoplados a proteina g y composiciones relacionadas.
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
KR0131678B1 (ko) * 1991-12-09 1998-04-17 유미꾸라 레이이찌 파라티로이드 호르몬류의 안정화 조성물
US5382658A (en) * 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone

Also Published As

Publication number Publication date
WO1994008613A2 (en) 1994-04-28
AU680631B2 (en) 1997-08-07
DK0663835T3 (da) 1997-09-01
KR950703359A (ko) 1995-09-20
GR3024157T3 (en) 1997-10-31
ITMI922331A1 (it) 1994-04-09
JPH08502271A (ja) 1996-03-12
DE69310528D1 (de) 1997-06-12
ES2103493T3 (es) 1997-09-16
US5880093A (en) 1999-03-09
EP0663835A1 (en) 1995-07-26
WO1994008613A3 (en) 1994-05-26
EP0663835B1 (en) 1997-05-07
KR100293846B1 (ko) 2001-09-17
AU5149993A (en) 1994-05-09
DE69310528T2 (de) 1997-09-11
ATE152628T1 (de) 1997-05-15
IT1255723B (it) 1995-11-13
NZ256679A (en) 1997-03-24
CA2146666A1 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
ITMI922331A0 (it) Uso di paratormone suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto protermine ed in generale per il trattamento della gestazione
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
PT735818E (pt) Proteinas inflamatorias de macrofagos pim-3 pim-4 e pim-1y
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
ZA874635B (en) Novel anti-inflammatory agents,pharmaceutical compositions and methods for reducing inflammation
IT1224795B (it) Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
IT9067434A0 (it) Procedimento per migliorare l'efficacia terapeutica di corticosteroidi liposolubili e composizione per l'attuazione di tale procedimento
IT8468281A1 (it) Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
HUP0001526A3 (en) Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions
ITRM910730A0 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" diradicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
IT1241631B (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
IT1251497B (it) Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
ITRM950589A0 (it) Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire malattie causate dalla sovrapproduzione di dette citochine naturali, e composizioni farmaceutiche cosi' ottenibili
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
HUT71838A (en) Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions
MY111746A (en) Therapeutic nucleosides.
ITRM930154A0 (it) Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
IT8909484A0 (it) Uso in terapia della 10-ammino-5,6diidro-11h= dibenzo (b,e) azepina-6,11-dione e derivati, quali farmaci utili per il trattamento dell'incontinenza urinaria
CA2251355A1 (en) Il-6 mutein
ITMI911439A0 (it) Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030